Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
20.00
0.32 (1.63%)
BSENSE

Feb 03

BSE+NSE Vol: 1228000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Vipul Organics
Valiant Organics
DMCC Speciality
Sudarshan Pharma
Kronox Lab
Amal
Jayant Agro Org.
Black Rose Indus
Plastiblends (I)
Chemcon Special.
Chembond Chemic.
Why is Sudarshan Pharma Industries Ltd ?
1
Flat results in Sep 25
  • PBT LESS OI(Q) At Rs 2.74 cr has Fallen at -42.8% (vs previous 4Q average)
  • NON-OPERATING INCOME(Q) is 43.27 % of Profit Before Tax (PBT)
2
Below par performance in long term as well as near term
  • Along with generating -36.62% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sudarshan Pharma for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sudarshan Pharma
-50.37%
-0.83
43.88%
Sensex
8.49%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
27.70%
EBIT Growth (5y)
51.12%
EBIT to Interest (avg)
2.42
Debt to EBITDA (avg)
5.22
Net Debt to Equity (avg)
1.54
Sales to Capital Employed (avg)
1.53
Tax Ratio
25.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.83%
ROCE (avg)
10.65%
ROE (avg)
12.34%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
29
Industry P/E
32
Price to Book Value
3.41
EV to EBIT
19.69
EV to EBITDA
18.28
EV to Capital Employed
1.95
EV to Sales
1.37
PEG Ratio
0.70
Dividend Yield
NA
ROCE (Latest)
9.90%
ROE (Latest)
11.61%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
PAT(9M)

At Rs 12.58 cr has Grown at 49.25%

NET SALES(Latest six months)

At Rs 336.88 cr has Grown at 37.93%

-3What is not working for the Company
INTEREST(9M)

At Rs 18.18 cr has Grown at 50.25%

Loading Valuation Snapshot...
Here's what is working for Sudarshan Pharma
Profit After Tax (PAT) - Nine Monthly
At Rs 12.58 cr has Grown at 49.25%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Latest six months
At Rs 336.88 cr has Grown at 37.93%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Sudarshan Pharma
Interest - Nine Monthly
At Rs 18.18 cr has Grown at 50.25%
over preceding nine months period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)